Prognosis
Pfizer Shot Effective, Safe, FDA Staff Says Before Meeting
- Documents set the stage for key advisory meeting Thursday
- Vaccine found effective across racial and ethnic groups, ages
This article is for subscribers only.
The coronavirus vaccine made by Pfizer Inc. and its German partner BioNTech SE is highly effective in preventing Covid-19 and there are no safety concerns that would prevent it from being granted an emergency-use authorization, according to a report by staff of the U.S. Food and Drug Administration.
The report offers a first look at the U.S. review of the vaccine ahead of a public meeting Thursday of outside advisers to the agency. The FDA could clear the shot shortly after the meeting, with as many as 6.4 million doses immediately available to kick off a vast immunization effort designed to end a pandemic that has killed more than 283,000 Americans.